Tejnaksh Healthcare Ltd

Tejnaksh Healthcare Ltd has announced the closure of its trading window for promoters, directors, designated employees, and connected persons. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code. The window will remain shut from July 01, 2026, until 48 hours after the declaration of financial results for the quarter and year ended June 30, 2026. This measure is standard practice to prevent potential insider trading during sensitive financial reporting periods.

Tejnaksh Healthcare Ltd has announced its audited financial results for the quarter and year ended March 31, 2026. The results, both consolidated and standalone, were approved by the Board of Directors on May 30, 2026. The audit report, conducted by M/s Maheshwari and Co, Chartered Accountants, expresses an unmodified opinion on the annual audited financial results. The consolidated financial results include the financial results of Tejvedaant Healthcare Private Limited, a subsidiary.

Tejnaksh Healthcare Ltd. has approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board also re-appointed M/s Kapil Tulsani & Associates as the Internal Auditor for the period April 1, 2026, to March 31, 2027. The company decided against proceeding with the proposed Rights Issue due to postponement of expansion plans. Maheshwari & Co. issued an unmodified opinion on the annual audited financial results.

Tejnaksh Healthcare Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the audited financial results (standalone & consolidated) for the quarter and financial year ended March 31, 2026. The trading window closure, which began on March 27, 2026, will remain in effect until 48 hours after the declaration of the audited financial results.

Tejnaksh Healthcare Ltd has announced the closure of its trading window for insider trading. This decision is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Internal Procedures and Conduct for Prevention of Insider Trading in Securities. The trading window for promoters, directors, designated employees, and other connected or designated persons of the company will be closed from April 01, 2026, till 48 hours after the declaration of Financial Results for the quarter and year ended March 31, 2026.

Tejnaksh Healthcare Ltd. has reported its unaudited consolidated financial results for the quarter ended 31st December 2025, with a 31.20% increase in profit before tax compared to the same period last year. The company's revenue from operations stands at INR 1,289.71 lakh, with a total expense of INR 1,001.44 lakh. The profit for the year attributable to equity holders of the parent is INR 232.78 lakh. The company operates in the medical and healthcare services sector and has no material impact from the new labor codes.

Tejnaksh Healthcare Ltd., a company based in Mumbai, Maharashtra, held a Board of Directors meeting on February 7, 2026, where they considered and approved the un-audited financial results (standalone & consolidated) for the quarter ended on December 31, 2025. The review report was submitted by Maheshwari & Co. Chartered Accountants, the independent auditor, in accordance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The review report confirmed that the statement was prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 and other recognized accounting principles generally accepted in India.

Tejnaksh Healthcare Ltd has announced that its Board of Directors will meet on February 7, 2026, to consider and approve the un-audited financial results for the quarter ended December 31, 2025. The meeting will be held at Shivprasad Harihar Singh Compound, Jogeshwari East, Mumbai. The trading window for dealing in the shares of the company was closed on December 28, 2025, and will remain closed until 48 hours after the declaration of the un-audited financial results.

Tejnaksh Healthcare Ltd has announced the closure of the trading window for dealing in securities of the company for Directors, KMPs, designated employees, and other connected persons. The closure will commence from January 1, 2026, and end 48 hours after the financial results for the quarter and year ending December 31, 2025, become generally available information. This announcement is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and its amendments.

Tejnaksh Healthcare Ltd. has announced its financial results for the quarter ended on 30th September 2025. The company reported a revenue from operations (net) of 1,289.71 Lakh, representing an increase compared to the previous quarters. The total expenses for the quarter stood at 1,113.14 Lakh, leading to a profit before tax of 176.57 Lakh. The company's profit for the quarter attributable to equity holders of the parent is 176.57 Lakh, and the earnings per share (EPS) (basic and diluted) is not annualized.